HK1002829A1 - Use of a monoclonal antibody against the 17-1a antigen for the manufacture of a medicament for the treatment of a gastrointestinal tumor - Google Patents

Use of a monoclonal antibody against the 17-1a antigen for the manufacture of a medicament for the treatment of a gastrointestinal tumor

Info

Publication number
HK1002829A1
HK1002829A1 HK98101926A HK98101926A HK1002829A1 HK 1002829 A1 HK1002829 A1 HK 1002829A1 HK 98101926 A HK98101926 A HK 98101926A HK 98101926 A HK98101926 A HK 98101926A HK 1002829 A1 HK1002829 A1 HK 1002829A1
Authority
HK
Hong Kong
Prior art keywords
antigen
medicament
manufacture
monoclonal antibody
treatment
Prior art date
Application number
HK98101926A
Other languages
English (en)
Inventor
Hubert J P Schoemaker
Richard A Carrano
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Inc filed Critical Centocor Inc
Publication of HK1002829A1 publication Critical patent/HK1002829A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/303—Liver or Pancreas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK98101926A 1986-07-09 1998-03-10 Use of a monoclonal antibody against the 17-1a antigen for the manufacture of a medicament for the treatment of a gastrointestinal tumor HK1002829A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88357286A 1986-07-09 1986-07-09

Publications (1)

Publication Number Publication Date
HK1002829A1 true HK1002829A1 (en) 1998-09-18

Family

ID=25382871

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98101926A HK1002829A1 (en) 1986-07-09 1998-03-10 Use of a monoclonal antibody against the 17-1a antigen for the manufacture of a medicament for the treatment of a gastrointestinal tumor

Country Status (9)

Country Link
US (2) US6444207B1 (fr)
EP (2) EP0252741B1 (fr)
JP (2) JP2979318B2 (fr)
AT (1) ATE159174T1 (fr)
CA (1) CA1341281C (fr)
DE (1) DE3752129T2 (fr)
ES (1) ES2110392T3 (fr)
GR (1) GR3025902T3 (fr)
HK (1) HK1002829A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643189B2 (en) 1988-09-06 1993-11-11 Xoma Corporation Production of chimeric mouse-human antibodies with specificity to human tumor antigens
EP0857176A1 (fr) * 1995-10-25 1998-08-12 Centocor B.V. PEPTIDES DERIVES DE L'Ep-CAM ANTIGENE EPITHELIAL HUMAIN ET LEUR EMPLOI
US20030044384A1 (en) 1997-10-09 2003-03-06 Pro-Virus, Inc. Treatment of neoplasms with viruses
CA2327439C (fr) * 1998-05-15 2005-07-05 Aphton Corporation Therapie combinee pour le traitement de tumeurs
MXPA01007148A (es) 1999-01-13 2002-03-27 Igeneon Krebs Immuntherapie Uso de anticuerpos para vacunacion anti-cancer.
HUP0302278A3 (en) 1999-04-15 2011-01-28 Pro Virus Treatment of neoplasms with viruses
JP2003505432A (ja) * 1999-07-23 2003-02-12 グラクソ グループ リミテッド 抗ｅｐ−ｃａｍ抗体と化学療法剤との組合せ
CA2441228A1 (fr) 2001-03-23 2002-10-03 Aphton Corporation Traitement combine du cancer du pancreas
US20090191232A1 (en) 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
US20100311954A1 (en) * 2002-03-01 2010-12-09 Xencor, Inc. Optimized Proteins that Target Ep-CAM
CA2519294A1 (fr) * 2003-03-24 2005-02-17 Wellstat Biologics Corporation Administration de virus de la maladie de newcastle
JP4689597B2 (ja) 2003-03-28 2011-05-25 レセプター バイオロジックス インク． ガストリンホルモン免疫アッセイ
AT500650B1 (de) 2003-04-17 2009-11-15 Altropus Gmbh Immunogener rekombinanter antikörper
US20050084913A1 (en) * 2003-04-22 2005-04-21 Maxygen, Inc. Novel tumor-associated antigens
CA2580965C (fr) 2004-09-22 2014-04-08 Receptor Biologix, Inc. Anticorps monoclonaux de progastrine
US7557190B2 (en) 2005-07-08 2009-07-07 Xencor, Inc. Optimized proteins that target Ep-CAM
EP2044949A1 (fr) 2007-10-05 2009-04-08 Immutep Utilisation de lag-3 recombinant ou ses dérivatifs pour déclencher la réponse immune des monocytes
GB201322626D0 (en) 2013-12-19 2014-02-05 Immutep S A Combined preparations for the treatment of cancer
JP6496529B2 (ja) * 2014-11-11 2019-04-03 株式会社Ｆｕｊｉ 特定方法、および特定装置
GB201500374D0 (en) 2015-01-09 2015-02-25 Immutep S A Combined preparations for the treatment of cancer
WO2017176380A1 (fr) * 2016-02-22 2017-10-12 The General Hospital Corporation Systèmes et procédés de ciblage sélectif de caractéristiques structurales dans le traitement des affections cutanées
JP7469225B2 (ja) 2017-06-15 2024-04-16 キャンサー アドヴァンシーズ インク． 腫瘍及び癌に対する体液性及び細胞性免疫を誘発するための組成物及び方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925922A (en) * 1983-02-22 1990-05-15 Xoma Corporation Potentiation of cytotoxic conjugates
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
EP0199141A3 (fr) * 1985-04-19 1988-07-20 Sloan-Kettering Institute For Cancer Research Anticorps monoclonaux contre le cancer gastro-intestinal humain

Also Published As

Publication number Publication date
US6444207B1 (en) 2002-09-03
DE3752129D1 (de) 1997-11-20
JP2979318B2 (ja) 1999-11-15
EP0252741A3 (fr) 1989-08-09
JP2000026312A (ja) 2000-01-25
JPS6360941A (ja) 1988-03-17
ATE159174T1 (de) 1997-11-15
GR3025902T3 (en) 1998-04-30
CA1341281C (fr) 2001-08-07
US20030072759A1 (en) 2003-04-17
EP0252741B1 (fr) 1997-10-15
DE3752129T2 (de) 1998-05-07
ES2110392T3 (es) 1998-02-16
EP0755683A1 (fr) 1997-01-29
JP3494592B2 (ja) 2004-02-09
EP0252741A2 (fr) 1988-01-13

Similar Documents

Publication Publication Date Title
GR3025902T3 (en) Use of a monoclonal antibody against the 17-1A antigen for the manufacture of a medicament for the treatment of a gastrointestinal tumor
EP0536275A4 (en) Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
SE7503542L (fr)
NZ210867A (en) Tumour-specific monoclonal antibodies, production thereof and use
HU9301794D0 (en) Medical preparative for treating chronical viral diseases of liver as well qs method for preparing said medicament
DE3168595D1 (en) New para-substituted 3-phenoxy-1-alkylamino-propanol-2-s having beta receptor blocking properties
EP0226419A3 (en) Anti-human ovarian cancer immunotoxins and methods of use thereof
Bernstein et al. Monoclonal antibody therapy of mouse leukemia
EP0194851A3 (fr) Thérapie de tumeurs humaines
GB2044775B (en) Process for the preparation of immunoglobulin for intravenous administration
IL76289A0 (en) Tumor therapeutic agent and a process for its preparation
DE3169348D1 (en) New substituted 3-phenoxy-1-alkoxycarbonyl-alkylamino-propanol-2-s having beta receptor blocking properties
Maloisel et al. Platin salts-induced hemolytic anemia: cisplatin-and the first case of carboplatin-induced hemolysis
DK0531419T3 (da) Bistriazener som kemoterapeutiske midler
IL62988A0 (en) Germanium compounds,a process for the preparation thereof,a process for the preparation of a medicine using such a germanium compound for the treatment of cancer,as well as the shaped medicine thus formed and obtained
ES8304581A1 (es) Procedimiento para preparar compuestos de estano.
PH16347A (en) Improved nitroglycerin infusion set for the intravenous administration of nitroglycerin solution
KR930702983A (ko) 난소암의 치료
GB1352414A (en) Histidine derivatives
Liszka et al. Glycophorin A expression in malignant hematopoiesis.
ZA813620B (en) Germanium compounds,a process for the preparation thereof,a process for the preparation of a medicine using such a germanium compound for the treatment of cancer,as well as the shaped medicine thus formed and obtained
UA36093A (uk) Спосіб лікування хронічного бронхіту
ES354632A1 (es) Procedimiento para la produccion de derivados de ciano.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20070708